The White House released an executive order Sunday evening (Sept. 13) that extends the president’s controversial most-favored nation policy to include Medicare Part D in addition to Part B, a move that could eventually drastically lower seniors’ drug costs but that policy experts view as a Hail Mary before the election and expect to be challenged in court. The brand pharmaceutical lobby immediately blasted the White House’s move. The executive order requires drug makers to sell their drugs to Medicare...